| 1 |
31375978 | Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer - the role of STAT3 and p21. | 2020 Aug |
1 |
| 2 |
32075387 | The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology. | 2020 Winter |
1 |
| 3 |
31817171 | In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment. | 2019 Dec 4 |
1 |
| 4 |
28972595 | Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1/PD-L1 pathway. | 2018 Apr |
3 |
| 5 |
29320977 | Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3. | 2018 Jan |
2 |
| 6 |
29848664 | Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. | 2018 May 30 |
2 |
| 7 |
30209121 | B-cell receptor-mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma. | 2018 Oct 25 |
1 |
| 8 |
28352655 | Panobinostat acts synergistically with ibrutinib in diffuse large B cell lymphoma cells with MyD88 L265P mutations. | 2017 Mar 23 |
1 |
| 9 |
25388373 | Inhibitors of BCR signalling interrupt the survival signal mediated by the micro-environment in mantle cell lymphoma. | 2015 Jun 15 |
1 |